Thrive: Building successful companies in the Madison Wisconsin USA region
May 25, 2010 by biotechcheck.com · Leave a Comment
Three Madison Wisconsin biotech/biomedical businesses discuss what makes their business successful in the Madison Region–from a startup (FluGen), a business just about to enter clinical trials (Quintessence) and a global headquarters with an IPO (TomoTherapy).
2003 European Biotechnology Vc Directory: European Venture Capital Companies And Contacts
May 23, 2010 by biotechcheck.com · Leave a Comment
Product Description
Annual, user-friendly directory of information contained in BioAbility’s comprehensive database of European venture capital firms active in biotechnology. Contents include indices as follows: Venture Capital Firms, Contact Names, Venture Capital Firms by Country, and Index of Biotechnology Companies and Investors. Spiral bound.
2003 European Biotechnology Vc Directory: European Venture Capital Companies And Contacts
First of Kalamazoo’s startup life-sciences companies to close; CeeTox acquiring assets of ADMETRx Inc.
May 21, 2010 by biotechcheck.com · Leave a Comment
First of Kalamazoo’s startup life-sciences companies to close; CeeTox acquiring assets of ADMETRx Inc.
An official with Kalamazoo-based CeeTox said Thursday that business is picking up again after the economic turmoil of 2009, and the ADMETRx acquisition will help CeeTox expand the services it offers to clients.
Read more on The Kalamazoo Gazette
The Boston Globe Unveils the Best Performing Massachusetts Companies in Annual Globe 100 Magazine
May 18, 2010 by biotechcheck.com · Leave a Comment
The Boston Globe Unveils the Best Performing Massachusetts Companies in Annual Globe 100 Magazine
BOSTON—-The Boston Globe’s annual Globe 100 magazine, an exclusive ranking of the best performing public companies based in Massachusetts, will be published tomorrow in The Boston Globe and on Boston.com.
Read more on Business Wire via Yahoo! Finance
Acorda Therapeutics Chief Executive Officer Ron Cohen Elected Chairman of BIO Emerging Companies Section
May 4, 2010 by biotechcheck.com · Leave a Comment
Acorda Therapeutics Chief Executive Officer Ron Cohen Elected Chairman of BIO Emerging Companies Section
HAWTHORNE, N.Y.—-Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President and CEO, has been elected chairman of the Biotechnology Industry Organization Emerging Companies Section.
Read more on Business Wire via Yahoo! Finance
